Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Mar 14, 2022
- Accession no.
- 0001209191-22-018347
- Filed
- Mar 14, 2022, 7:16 AM ET
- Trade date
- Mar 11, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $312.9K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | Common Stock | PPurchaseAcquired | +100 | $3.12 | +$312 | 194,621,794 | Indirect | |
| Mar 11, 2022 | Common Stock | PPurchaseAcquired | +26,863 | $3.13 | +$83,946.88 | 194,648,657 | Indirect | |
| Mar 11, 2022 | Common Stock | PPurchaseAcquired | +73,037 | $3.13 | +$228,605.81 | 194,721,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.